1,2-dipalmitoylphosphatidylcholine has been researched along with lucinactant in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bancalari, A; Bancalari, E; d'Agostino, R; Gadzinowski, J; Kopelman, B; Kornacka, MK; Massaro, J; Merritt, TA; Moya, FR; Salinas, V; Schaber, CJ; Segal, R; Tsai, H | 1 |
Kattwinkel, J | 1 |
Pfister, RH; Soll, RF; Wiswell, T | 1 |
1 review(s) available for 1,2-dipalmitoylphosphatidylcholine and lucinactant
Article | Year |
---|---|
Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Phosphatidylglycerols; Phospholipids; Proteins; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 2007 |
1 trial(s) available for 1,2-dipalmitoylphosphatidylcholine and lucinactant
Article | Year |
---|---|
A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Female; Humans; Incidence; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Phosphatidylglycerols; Proteins; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Analysis | 2005 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and lucinactant
Article | Year |
---|---|
Synthetic surfactants: the search goes on.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphatidylglycerols; Phospholipids; Proteins; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 2005 |